# Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass

> **NCT00823082** · PHASE2 · COMPLETED · sponsor: **Instituto Grifols, S.A.** · enrollment: 200 (actual)

## Conditions studied

- Acquired Antithrombin III Deficiency
- Coronary Artery Bypass

## Interventions

- **DRUG:** Antithrombin III

## Key facts

- **NCT ID:** NCT00823082
- **Lead sponsor:** Instituto Grifols, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-09
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823082, "Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00823082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*